Bo Karlsson
Doktorand vid Institutionen för folkhälso- och vårdvetenskap; Allmänmedicin
- Mobiltelefon:
- 070-227 81 26
- E-post:
- bo.karlsson@uu.se
- Besöksadress:
- BMC, Husargatan 3
- Postadress:
- Box 564
751 22 UPPSALA
Mer information visas för dig som medarbetare om du loggar in.
Publikationer
Senaste publikationer
- Neuropeptide Y and measures of stress in a longitudinal study of women with the fibromyalgia syndrome (2023)
- Inflammation and Interferon Signatures in Peripheral B-Lymphocytes and Sera of Individuals With Fibromyalgia (2022)
- Near-patient testing of blood cell counts using HemoScreen™ point of care instrument in a primary care setting (2022)
- Decline of substance P levels after stress management with cognitive behaviour therapy in women with the fibromyalgia syndrome (2019)
- Rapid testing of red blood cell parameters in primary care patients using HemoScreen™ point of care instrument (2019)
Alla publikationer
Artiklar
- Neuropeptide Y and measures of stress in a longitudinal study of women with the fibromyalgia syndrome (2023)
- Inflammation and Interferon Signatures in Peripheral B-Lymphocytes and Sera of Individuals With Fibromyalgia (2022)
- Near-patient testing of blood cell counts using HemoScreen™ point of care instrument in a primary care setting (2022)
- Decline of substance P levels after stress management with cognitive behaviour therapy in women with the fibromyalgia syndrome (2019)
- Rapid testing of red blood cell parameters in primary care patients using HemoScreen™ point of care instrument (2019)
- The effect of group-based cognitive behavioral therapy on inflammatory biomarkers in patients with coronary disease (2018)
- Seasonal variability of NT-proBNP in Swedish primary care patients (2017)
- Cognitive behaviour therapy in women with fibromyalgia (2015)
- Evaluation of the Alere D-dimer test for point of care testing (2014)
- On the influence of vitamin K-rich vegetables and wine on the effectiveness of warfarin treatment (1986)
Konferenser
- Neuropeptide Y levels are reduced after cognitive behavioural therapy (CBT) in women with fibromyalgia (FMS) (2014)
- Substance P (SP) levels are reduced after distress management with cognitive behavioural therapy (CBT) in women with the fibromyalgia syndrome (FMS) (2012)
- A randomised clinical trial of stress management in women with the fibromyalgia syndrome (FMS) (2010)